Cargando…
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
TMPRSS2-ERG has been proposed to be a prognostic marker for prostate cancer. The aim of this study was to identify changes in metabolism, genes and biochemical recurrence related to TMPRSS2-ERG by using an integrated approach, combining metabolomics, transcriptomics, histopathology and clinical data...
Autores principales: | Hansen, Ailin Falkmo, Sandsmark, Elise, Rye, Morten Beck, Wright, Alan J., Bertilsson, Helena, Richardsen, Elin, Viset, Trond, Bofin, Anna M., Angelsen, Anders, Selnæs, Kirsten M., Bathen, Tone Frost, Tessem, May-Britt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173117/ https://www.ncbi.nlm.nih.gov/pubmed/27276682 http://dx.doi.org/10.18632/oncotarget.9817 |
Ejemplares similares
-
A novel non-canonical Wnt signature for prostate cancer aggressiveness
por: Sandsmark, Elise, et al.
Publicado: (2016) -
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer
por: Rye, Morten Beck, et al.
Publicado: (2014) -
Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
por: Giskeødegård, Guro F., et al.
Publicado: (2013) -
SFRP4 gene expression is increased in aggressive prostate cancer
por: Sandsmark, Elise, et al.
Publicado: (2017) -
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer
por: Tessem, May-Britt, et al.
Publicado: (2016)